The Chemours Company (NYSE:CC) Receives $17.56 Consensus PT from Analysts
The Chemours Company (NYSE:CC – Get Free Report) has been assigned an average rating of “Moderate Buy” from the nine ratings firms that are currently covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year […]
The Chemours Company (NYSE:CC – Get Free Report) has been assigned an average rating of “Moderate Buy” from the nine ratings firms that are currently covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year […]
